← Search & browse all drugs

methoserpidine and diuretics

C02LA04

Forms & Strengths

Combination tablets: methoserpidine combined with various diuretics (e.g., benzthiazide, chlorthalidone)

Adult Dosing

Hypertension: Initial dose typically 1 tablet daily, adjusted based on blood pressure response and tolerability
Maintenance: Titrated to the lowest effective dose of both components

Pediatric Dosing

Safety and efficacy in pediatric patients have not been established

Indications

Management of essential hypertension

Mechanism of Action

Methoserpidine: Rauwolfia alkaloid acting as a centrally and peripherally acting sympatholytic, depleting catecholamines and serotonin stores in nerve terminals
Diuretic: Enhances sodium and water excretion by the kidneys, reducing blood volume and peripheral vascular resistance

Contraindications

Known hypersensitivity to methoserpidine, rauwolfia alkaloids, or sulfonamide-derived diuretics
Active peptic ulcer disease or ulcerative colitis
History of depression
Severe renal impairment or anuria
Concurrent use with monoamine oxidase inhibitors (MAOIs)

Adverse Reactions

Central nervous system: Depression, drowsiness, fatigue, nightmares
Cardiovascular: Bradycardia, orthostatic hypotension, syncope
Gastrointestinal: Nausea, vomiting, diarrhea, increased gastric secretion
Metabolic: Electrolyte imbalances (hypokalemia, hyponatremia, hyperuricemia) secondary to the diuretic component
Other: Nasal congestion, impotence

Drug Interactions

MAOIs: Risk of severe CNS excitation and hypertension
Digitalis glycosides: Increased risk of cardiac arrhythmias due to diuretic-induced hypokalemia
Lithium: Decreased renal clearance of lithium, increasing the risk of toxicity
Antihypertensives/Vasodilators: Potentiation of blood pressure-lowering effects leading to severe hypotension
CNS depressants (alcohol, barbiturates): Enhanced sedative effects

Curated Content: Needs Vetting Before Put to Clinical Use